FDAFDA · Food and drugs·Recall number D-0265-2022
5% Dextrose Injection, USP, 50 mL ADD-Vantage Unit, Rx only, Distributed by Hospira, INC., Lake Forest, IL 60045 USA, NDC 0409-7100-68/0409-7100-66
Published December 8, 2021 · Recall initiated: November 30, 2021
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of sterility assurance: bag has the potential to leak.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- DEXTROSE
- Manufacturer
- Pfizer Inc.
- Distributor
- USA Nationwide
- Lot
- Lot: 4923608 Exp. 1MAY2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.